Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

BMJ Open

Topics

Medicine

Pathology

Physiology

Internal Medicine

Endocrinology

Show all topics

DOI

10.1136/bmjopen-2023-081401

License

CC-BY

Other Formats

PDF